Analysis of Infections and All-Cause Mortality in Phase II, Phase III, and Long-Term Extension Studies of Tofacitinib in Patients With Rheumatoid Arthritis
Identificadores
Identificadores
Data de publicación
2014Título da revista
Arthritis and Rheumatology
Tipo de contido
Artigo